Objective: While N-terminal pro-brain natriuretic peptide (NT-proBNP has been established as an important biomarker in the clinical setting where it is used in the diagnosis of cardiac failure, evaluation of the effectiveness of treatment and making prognoses, it still does not have a clear role in health check-ups. We therefore investigated the significance of NT-proBNP measurements in Ningen Dock.
Methods: Our subjects were 5,084 persons who underwent our association's Ningen Dock from January 15 to March 9 2009. Persons with renal failure (creatinine over 2 mg/dL) and those under treatment for cardiac disease and hypertension were eliminated leaving 4,225 as the subjects for our investigation. In them, we examined relationships between age, gender, blood pressure, blood chemical data, ECGs and NT-proBNP. Next, percentages of persons with high NT-proBNP levels (over 109 pg/mL) were examined with respect to hypertension and ECG abnormalities.
Results: Age, gender, systolic blood pressure, LDL-C, albumin, red blood cell count, fasting glucose, high-sensitive CRP, supraventricular extrasystole, ventricular extrasystole, left bundle branch block, atrial flutter/atrial fibrillation and left ventricular hypertrophy, independently, were significantly associated with NT-proBNP. The percentage of subjects with high NT-proBNP levels was 5% for subjects with normal blood pressure and no ECG abnormalities, while it was 10% for hypertension and left ventricular hypertrophy and 60% for atrial flutter/atrial fibrillation.
Conclusion: Based on the above findings, NT-proBNP measurement would be useful in Ningen Dock.
View full abstract